Management of late-presenting patients with HIV infection

Jürgen K. Rockstroh, Jose Gatell, Roland Landman, Andrea Antinori

Research output: Contribution to journalArticle

Abstract

Managing patients who present late with HIV infection is challenging. All late-presenting patients should have an individual treatment plan that encompasses both antiretroviral therapy and, where necessary, treatment for opportunistic diseases. Timely initiation of treatment in late presenters is crucial but the optimal time to start therapy depends on many individual factors, including the presence of opportunistic infection and potential drug-drug interactions. Primary drug resistance is an important contributor to poor clinical outcomes in HIV; resistance profiling before treatment initiation is therefore recommended. The choice of initial HIV treatment should reflect patient characteristics, the results of resistance testing and the complexity of concomitant disease.

Original languageEnglish
Pages (from-to)25-30
Number of pages6
JournalAntiviral Therapy
Volume15
Issue numberSUPPL. 1
DOIs
Publication statusPublished - 2010

Fingerprint

HIV Infections
Therapeutics
HIV
Opportunistic Infections
Drug Interactions
Drug Resistance
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Management of late-presenting patients with HIV infection. / Rockstroh, Jürgen K.; Gatell, Jose; Landman, Roland; Antinori, Andrea.

In: Antiviral Therapy, Vol. 15, No. SUPPL. 1, 2010, p. 25-30.

Research output: Contribution to journalArticle

Rockstroh, JK, Gatell, J, Landman, R & Antinori, A 2010, 'Management of late-presenting patients with HIV infection', Antiviral Therapy, vol. 15, no. SUPPL. 1, pp. 25-30. https://doi.org/10.3851/IMP1527
Rockstroh, Jürgen K. ; Gatell, Jose ; Landman, Roland ; Antinori, Andrea. / Management of late-presenting patients with HIV infection. In: Antiviral Therapy. 2010 ; Vol. 15, No. SUPPL. 1. pp. 25-30.
@article{c27e2d5d25f74005b3b69736a7f273b3,
title = "Management of late-presenting patients with HIV infection",
abstract = "Managing patients who present late with HIV infection is challenging. All late-presenting patients should have an individual treatment plan that encompasses both antiretroviral therapy and, where necessary, treatment for opportunistic diseases. Timely initiation of treatment in late presenters is crucial but the optimal time to start therapy depends on many individual factors, including the presence of opportunistic infection and potential drug-drug interactions. Primary drug resistance is an important contributor to poor clinical outcomes in HIV; resistance profiling before treatment initiation is therefore recommended. The choice of initial HIV treatment should reflect patient characteristics, the results of resistance testing and the complexity of concomitant disease.",
author = "Rockstroh, {J{\"u}rgen K.} and Jose Gatell and Roland Landman and Andrea Antinori",
year = "2010",
doi = "10.3851/IMP1527",
language = "English",
volume = "15",
pages = "25--30",
journal = "Antiviral Therapy",
issn = "1359-6535",
publisher = "International Medical Press Ltd",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Management of late-presenting patients with HIV infection

AU - Rockstroh, Jürgen K.

AU - Gatell, Jose

AU - Landman, Roland

AU - Antinori, Andrea

PY - 2010

Y1 - 2010

N2 - Managing patients who present late with HIV infection is challenging. All late-presenting patients should have an individual treatment plan that encompasses both antiretroviral therapy and, where necessary, treatment for opportunistic diseases. Timely initiation of treatment in late presenters is crucial but the optimal time to start therapy depends on many individual factors, including the presence of opportunistic infection and potential drug-drug interactions. Primary drug resistance is an important contributor to poor clinical outcomes in HIV; resistance profiling before treatment initiation is therefore recommended. The choice of initial HIV treatment should reflect patient characteristics, the results of resistance testing and the complexity of concomitant disease.

AB - Managing patients who present late with HIV infection is challenging. All late-presenting patients should have an individual treatment plan that encompasses both antiretroviral therapy and, where necessary, treatment for opportunistic diseases. Timely initiation of treatment in late presenters is crucial but the optimal time to start therapy depends on many individual factors, including the presence of opportunistic infection and potential drug-drug interactions. Primary drug resistance is an important contributor to poor clinical outcomes in HIV; resistance profiling before treatment initiation is therefore recommended. The choice of initial HIV treatment should reflect patient characteristics, the results of resistance testing and the complexity of concomitant disease.

UR - http://www.scopus.com/inward/record.url?scp=77952071799&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952071799&partnerID=8YFLogxK

U2 - 10.3851/IMP1527

DO - 10.3851/IMP1527

M3 - Article

C2 - 20442458

AN - SCOPUS:77952071799

VL - 15

SP - 25

EP - 30

JO - Antiviral Therapy

JF - Antiviral Therapy

SN - 1359-6535

IS - SUPPL. 1

ER -